Advertisement
Canada markets open in 2 hours 50 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7313
    +0.0015 (+0.21%)
     
  • CRUDE OIL

    82.85
    +0.04 (+0.05%)
     
  • Bitcoin CAD

    86,795.42
    -4,021.33 (-4.43%)
     
  • CMC Crypto 200

    1,351.72
    -30.85 (-2.23%)
     
  • GOLD FUTURES

    2,339.30
    +0.90 (+0.04%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,508.25
    -156.25 (-0.88%)
     
  • VOLATILITY

    16.16
    +0.19 (+1.19%)
     
  • FTSE

    8,088.60
    +48.22 (+0.60%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6814
    -0.0005 (-0.07%)
     

This Top Dividend Stock is Still Undervalued

Analysts have sounded a recent warning for the insurance industry as it comes out of the COVID-19 pandemic. Predictably, top insurers are expected to incur deeper-than-expected losses in the face of this crisis. Regardless, I’m still targeting the top dividend stock we will look at today.

Manulife Financial (TSX:MFC)(NYSE:MFC) is one of the top insurance providers and financial services companies in Canada. Shares of Manulife have dropped 26% in 2020 as of late afternoon trading on August 6. The company released its second quarter 2020 results on August 5. It showed a marked improvement from a dim first quarter.

The company’s Asian business has continued to be a source of strength during this global crisis. Its Asia-based business returned to growth in Q2 2020.

Manulife managed to beat analyst expectations across the board. Profit rose 3.8% over the previous quarter to $489 million. Meanwhile, the global stock market rebound powered an increase in its assets under management. However, its global wealth management division still saw earnings fall 1.7% from the previous year.

ADVERTISEMENT

Read:

Shares of Manulife last possessed a price-to-earnings ratio of 8.3 and a price-to-book value of 0.7. This puts the stock in very attractive value territory. Moreover, Manulife has a phenomenal track record as a dividend payer. It currently offers a quarterly dividend of $0.28 per share. This represents a tasty 5.9% yield.

Manulife is back on track, its stock is undervalued, and it is a star as a dividend payer. Investors should still look to scoop up Manulife today.